Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of New Trio Combination Versus Kligman's Formula In Treatment of Melasma

NCT07676994 is registered in ClinicalTrials.gov with Ghurki Trust and Teaching Hospital as lead sponsor.

NCT NCT07676994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07676994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of New Trio Combination Versus Kligman's Formula In Treatment of Melasma
Lead sponsor
Ghurki Trust and Teaching Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 7, 2025
Completion date
January 1, 2026
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma